{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:04:11Z","timestamp":1774343051205,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The tolerance and safety of vaccination in pregnancy should be assessed in local populations based on ethnic differences across countries. Therefore, this study aimed to determine the tolerability of the BNT162b2 mRNA vaccination in pregnancy in a Polish population. An online questionnaire enquiring about the safety and tolerability of the BNT162b2 mRNA vaccine was distributed to pregnant and non-pregnant female healthcare professionals who had voluntarily received one or two doses of the COVID-19 vaccine in Poland. The two groups were compared simultaneously considering the COVID-19 infection status before vaccination. Compared with that noted in the control group, pregnant women in the COVID-19-free group were less likely to have fever (p = 0.002) or gastrointestinal symptoms (p = 0.009) after the second dose. In the COVID-19-exposed group, pregnant women were less likely to experience local skin reactions (p = 0.009), and myalgia (p = 0.003) after the first dose. After the second dose, the only noticeable difference was a lower incidence of myalgia (p = 0.001) in pregnant women. The tolerability of the BNT162b2 mRNA COVID-19 vaccine was similar in both the groups. No severe local, generalised, or pregnancy complications related to mother or foetus were observed. Good tolerability of the BNT162b2 mRNA COVID-19 vaccine in pregnancy in the Polish population may facilitate the decision to vaccinate pregnant women against COVID-19.<\/jats:p>","DOI":"10.3390\/vaccines10020200","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T22:01:57Z","timestamp":1643320917000},"page":"200","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Tolerability of the BNT162b2 COVID-19 Vaccine during Pregnancy among Polish Healthcare Professionals"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0460-1658","authenticated-orcid":false,"given":"Wojciech","family":"Zdanowski","sequence":"first","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Gynaecological Oncology Clinical Ward, Regional Specialist Hospital, ul. \u017bo\u0142nierska 18, 10-561 Olsztyn, Poland"},{"name":"Department of Obstetrics and Gynaecology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-561 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Markiewicz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-229 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Zdanowska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-229 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina","family":"Lipi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Gynaecological Oncology Clinical Ward, Regional Specialist Hospital, ul. \u017bo\u0142nierska 18, 10-561 Olsztyn, Poland"},{"name":"Department of Obstetrics and Gynaecology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-561 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Wa\u015bniewski","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Gynaecological Oncology Clinical Ward, Regional Specialist Hospital, ul. \u017bo\u0142nierska 18, 10-561 Olsztyn, Poland"},{"name":"Department of Obstetrics and Gynaecology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, 10-561 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.7150\/ijms.49923","article-title":"Impact of COVID-19 on Pregnancy","volume":"18","author":"Wang","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ijgo.13533","article-title":"COVID-19 infection in pregnant women: Review of maternal and fetal outcomes","volume":"152","author":"Salem","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2208","article-title":"Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis","volume":"31","author":"Jafari","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e12956","DOI":"10.1111\/ijn.12956","article-title":"COVID-19 and pregnancy: A scoping review on pregnancy characteristics and outcomes","volume":"27","author":"Wernet","year":"2021","journal-title":"Int. J. Nurs. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"E540","DOI":"10.1503\/cmaj.202604","article-title":"The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis","volume":"193","author":"Wei","year":"2021","journal-title":"CMAJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ajog.2020.07.049","article-title":"Vertical transmission of coronavirus disease 2019: A systematic review and meta-analysis","volume":"224","author":"Kotlyar","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Donders, G.G.G., Grinceviciene, S., Haldre, K., Lonnee-Hoffmann, R., Donders, F., Tsiakalos, A., Adriaanse, A., Martinez de Oliveira, J., Ault, K., and Mendling, W. (2021). On The behalf of the Covid-Isidog Guideline Group. ISIDOG Consensus Guidelines on COVID-19 vaccination for women before, during and after Pregnancy. J. Clin. Med., 10.","DOI":"10.20944\/preprints202104.0530.v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"735394","DOI":"10.3389\/fcimb.2021.735394","article-title":"COVID-19 Vaccination in Pregnancy and Lactation: Current research and gaps in understanding","volume":"11","author":"Shook","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s40264-021-01131-6","article-title":"Ilmiovaccino COVID19 collaborating group. COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: Overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety","volume":"44","author":"Luxi","year":"2021","journal-title":"Drug Saf."},{"key":"ref_10","unstructured":"(2020, December 03). ACOG Vaccinating Pregnant and Lactating Patients against COVID-19. Available online: https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2020\/12\/vaccinating-pregnant-and-lactating-patients-against-covid-19."},{"key":"ref_11","unstructured":"(2021, April 06). COVID-19 (Coronavirus Disease): People with Certain Medical Conditions, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html."},{"key":"ref_12","unstructured":"(2021, April 06). COVID-19 (Coronavirus Disease): Information about COVID-19 Vaccines for People Who Are Pregnant or Breastfeeding, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/pregnancy.html."},{"key":"ref_13","unstructured":"Royal College of Obstetricians and Gynaecologists (2021, April 06). Updated Advice on COVID-19 Vaccination in Pregnancy and Women Who Are Breastfeeding. Available online: https:\/\/www.rcog.org.uk\/en\/news\/updated-advice-on-covid-19-vaccination-in-pregnancy-and-women-who-are-breastfeeding\/."},{"key":"ref_14","unstructured":"(2021, April 24). PTGiP Position Statement on Vaccination of Pregnant Women against COVID19. Available online: https:\/\/www.ptgin.pl\/sites\/scm\/files\/2021-09\/04.2021%20Stanowisko%20PTGiP%20dotycz\u0105ce%20szczepie\u0144%20kobiet%20ci\u0119\u017carnych%20przeciwko%20COVID19.pdf."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Damasceno, D.H.P., Amaral, A.A., Silva, C.A., Sim\u00f5es, E., and Silva, A.C. (2021, June 16). The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/34473613\/.","DOI":"10.2174\/0929867328666210902094254"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1016\/j.vaccine.2021.09.012","article-title":"Prenatal maternal COVID-19 vaccination and pregnancy outcomes","volume":"39","author":"Wainstock","year":"2021","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e150790","DOI":"10.1172\/JCI150790","article-title":"The Israeli study of Pfizer BNT162b2 vaccine in pregnancy: Considering maternal and neonatal benefits","volume":"131","author":"Burd","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Morales-N\u00fa\u00f1ez, J.J., Mu\u00f1oz-Valle, J.F., Meza-L\u00f3pez, C., Wang, L.F., Machado Sulbar\u00e1n, A.C., Torres-Hern\u00e1ndez, P.C., Bedolla-Barajas, M., De la O-G\u00f3mez, B., Balc\u00e1zar-F\u00e9lix, P., and Hern\u00e1ndez-Bello, J. (2021). Neutralizing antibodies titers and side effects in response to BNT162b2 vaccine in healthcare workers with and without prior SARS-CoV-2 infection. Vaccines, 9.","DOI":"10.3390\/vaccines9070742"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"COVE Study Group. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1188\/10.CJON.E10-E21","article-title":"Infusion reactions: Diagnosis, assessment, and management","volume":"14","author":"Vogel","year":"2010","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100467","DOI":"10.1016\/j.ajogmf.2021.100467","article-title":"Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy","volume":"3","author":"Theiler","year":"2021","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.vaccine.2021.11.090","article-title":"Prior COVID-19 infection is associated with increased adverse events (AEs) after the first, but not the second, dose of the BNT162b2\/Pfizer vaccine","volume":"40","author":"Raw","year":"2021","journal-title":"Vaccine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.vaccine.2021.06.054","article-title":"Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study","volume":"39","author":"Baldolli","year":"2021","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2020.07.013","article-title":"Immunology and the immunological response in pregnancy","volume":"76","author":"Orefice","year":"2021","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"572567","DOI":"10.3389\/fimmu.2020.572567","article-title":"Innate immune responses to acute viral infection during pregnancy","volume":"11","author":"Cornish","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_27","first-page":"225","article-title":"Interleukin 35: An overview","volume":"27","author":"Zdanowska","year":"2020","journal-title":"Pol. Ann. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_29","first-page":"4418","article-title":"Side effects after COVID-19 vaccinations among residents of Poland","volume":"25","author":"Czudy","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.3346\/jkms.2021.36.e153","article-title":"Adverse reactions of the second dose of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in Korea","volume":"36","author":"Lee","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.15585\/mmwr.mm6932e3","article-title":"Hospitalization rates and characteristics of children aged <18 Years hospitalized with laboratory-confirmed COVID-19 COVID-NET, 14 States, March 1\u2013July 25, 2020","volume":"69","author":"Kim","year":"2020","journal-title":"Morb Mortal Wkly Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e154834","DOI":"10.1172\/JCI154834","article-title":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine","volume":"131","author":"Beharier","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zdanowski, W., and Wa\u015bniewski, T. (2021). Evaluation of SARS-CoV-2 spike protein antibody titers in cord blood after COVID-19 vaccination during pregnancy in Polish healthcare workers: Preliminary results. Vaccines, 9.","DOI":"10.22541\/au.162023176.65260617\/v1"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/2\/200\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:08:48Z","timestamp":1760134128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/2\/200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["vaccines10020200"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10020200","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}